14.6 %The prevalence of low ABI was 14.6% in the study group of HIV-infected participants in Kwara State, Nigeria.
NigeriaAOMIobserved 2018published 2019BMC public healthPubMeddocument of 11 observations
Gold tier: mechanically validated evidence, with its primary source.
8,823 evidence items · page 111 / 353
14.6 %The prevalence of low ABI was 14.6% in the study group of HIV-infected participants in Kwara State, Nigeria.
NigeriaAOMIobserved 2018published 2019BMC public healthPubMeddocument of 11 observations
1,000 copies/mLThe intervention showed a significant effect on virologic control <1000 copies per milliliter (odds ratio = 1.42).
NigeriaVIH/sidapublished 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations
37.5 %CRF02_AG was the major HIV-1 subtype, accounting for 37.5% of cases.
NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations
18 %Prevalence of placental parasitaemia was 18% in the intervention group and 40.6% in the control group.
Nigeriapaludismepublished 2024West African journal of medicinePubMeddocument of 5 observations
Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — were vaccinating against mpox during January–February 2025.
Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations
54 yearsThe mean age at diagnosis of diabetes mellitus was 54 years.
Nigeriadiabète (non précisé)published 2024West African journal of medicinePubMeddocument of 10 observations
2.4 odds_ratioBeing resident in Nigeria was independently associated with increased risk of restrictive spirometry (OR 2.4, 95% CI 1.1 to 4.9).
Nigeriadrépanocytosepublished 2019ThoraxPubMeddocument of 7 observations
19.3 %Probable chronic pulmonary aspergillosis was 19.3% at 6 months post-PTB therapy.
Nigeriapulmonary aspergillosis · tuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations
6.7 aORIn the presence of high-risk HPV, community state type III (CST-III) was associated with high-grade squamous intraepithelial lesion or invasive cervical cancer with an adjusted odds ratio of 6.7.
Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · high-risk human papillomavirusobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations
70.7 %Access to malaria case management aid was 70.7% in government-supported primary healthcare centres.
Nigeriapaludismepublished 2025The Nigerian postgraduate medical journalPubMeddocument of 11 observations
1.45 genera_per_sampleThe average number of different viral genera per sample was 1.45 in children and adolescents shortly after type 1 diabetes onset.
Nigeriadiabète de type 1published 2021Pediatric diabetesPubMeddocument of 6 observations
87.5 %Retention in care at 48 weeks was 87.5% among youth with HIV in Nigeria in a single-arm trial.
NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations
0.12 %Among 2386 initially uninfected pregnant women in Nigeria followed until delivery, the seroconversion rate for HIV-HBV dual infection was 0.12%.
Nigeriahépatite B · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations
20.8 %Among HPV-positive individuals, 20.8% had dual infections.
Nigeriainfection à HPVpublished 2019PloS onePubMeddocument of 7 observations
26 clinicians26 clinicians had used saliva for research purposes.
Nigeriaresearch purposespublished 2019The Pan African medical journalPubMeddocument of 17 observations
Comprehensive HIV/AIDS knowledge remains low among young people in Nigeria.
NigeriaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 5 observations
40 per_µlParasite density ranged from 40 to 203,883 parasites per microliter of blood.
Nigeriapaludismepublished 2013Medical principles and practice : international journal of the Kuwait University, Health Seurope_pmcdocument of 10 observations
37.8 %Thirty-one (37.8%) of the breast cancer patients were seen during the first year of follow-up.
Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations
159 casesThe study evaluated 159 cases of acquired drug resistance among persons living with HIV receiving combination antiretroviral therapy.
NigeriaVIH/sidaobserved 2004–2011published 2020AIDS research and therapyPubMeddocument of 7 observations
32.1 %Less than one third of the respondents, 32.1%, had good knowledge of malaria vaccination.
Nigeriapaludismeobserved 2023published 2025African health sciencesPubMeddocument of 6 observations
60 %The total knowledge score of HIV PEP among doctors was 60.0% with a standard deviation of 10.2%.
NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 6 observations
12 %Low birth weight occurred in 12.0% of HIV-exposed babies and 13.5% of non-exposed babies.
NigeriaVIH/sidaobserved 2009-2015published 2019West African journal of medicinePubMeddocument of 4 observations
Adherence to Option B+ ART can reduce the risk of mother-to-child transmission (MTCT) of HIV to 1-2% as against 15-40% without treatment.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations
48.4 %Awareness of hepatitis C virus infection among pregnant women in Nigeria was 48.4%.
Nigeriahépatite Cpublished 2021Women's health (London, England)PubMeddocument of 7 observations
16.7 %Disseminated tuberculosis was diagnosed in 6 (16.7%) of the 36 children.
Nigeriadisseminated tuberculosispublished 2026Annals of African medicinePubMeddocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.